Quantifying Uterine Elastography in Menstruating Women

Description

This study is aiming to characterize the elasticity of the female reproductive tract including the uterus, cervix and ovary using shear wave elastography at different times during the menstrual cycle and define the standard reference range of normal uterine and ovarian elasticity. By doing so, the potential of using shear wave elastography to diagnose and predict outcomes for patients seeking fertility treatment might be established.

Conditions

Infertility (IVF Patients), Infertility Assisted Reproductive Technology

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is aiming to characterize the elasticity of the female reproductive tract including the uterus, cervix and ovary using shear wave elastography at different times during the menstrual cycle and define the standard reference range of normal uterine and ovarian elasticity. By doing so, the potential of using shear wave elastography to diagnose and predict outcomes for patients seeking fertility treatment might be established.

Characterizing Uterine and Ovarian Tissue Stiffness Via Shear Wave Elastography in Non-Infertile, Fertile, and Infertile Women with Normal Anatomy Across the Menstrual Cycle: a Pilot Study

Quantifying Uterine Elastography in Menstruating Women

Condition
Infertility (IVF Patients)
Intervention / Treatment

-

Contacts and Locations

Basking Ridge

RMA, Basking Ridge, New Jersey, United States, 07920

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with normal menstrual cycles lasting 28-34 days
  • * Patients with normal uterine anatomy
  • * Patients with no prior pregnancy history including miscarriages, terminations, ectopic pregnancies, preterm deliveries, or full-term deliveries
  • * Patient who have no known infertility (i.e. women who have not tried to conceive)
  • * BMI ≥ 35
  • * Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
  • * History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
  • * History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of -endometrioma)
  • * History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
  • * Currently present or surgically corrected uterine anomalies
  • * Ultrasound evidence of or history of communicating hydrosalpinx
  • * Ultrasound evidence of or history of leiomyomas
  • * Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
  • * Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Reproductive Medicine Associates of New Jersey,

Study Record Dates

2026-12